ProSomnus Inc. (OSA)
0.47
0.00 (0.00%)
At close: Jan 16, 2025, 9:00 PM
Company Description
ProSomnus, Inc. manufactures precision oral appliance therapy devices for the treatment of obstructive sleep apnea (OSA).
The company was founded in 2016 and is based in Pleasanton, California.
ProSomnus Inc.
| Country | United States |
| IPO Date | Jul 28, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 136 |
| CEO | Leonard Liptak |
Contact Details
Address: 5860 West Las Positas Boulevard Pleasanton, California United States | |
| Website | https://www.ProSomnus.com |
Stock Details
| Ticker Symbol | OSA |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001934064 |
| CUSIP Number | 50535E108 |
| ISIN Number | US50535E1082 |
| Employer ID | 00-0000000 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Leonard Liptak | Co-Founder, Chief Executive Officer & Director |
| Brian B. Dow | Chief Financial Officer & Corporate Secretary |
| Sung Kim | Co-Founder & Chief Technology Officer |
| Dr. John E. Remmers M.D. | Chief Scientist |
| Dr. Shouresh Charkhandeh D.D.S. | Global Scientific Committee Chair |
| Heather Whalen | Vice President of Global Marketing Services |
| Laing F. Rikkers | Co-founder & Executive Chairman |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 05, 2024 | 15-12G | Filing |
| Aug 02, 2024 | S-8 POS | Filing |
| Aug 02, 2024 | S-8 POS | Filing |
| Aug 02, 2024 | POS AM | Filing |
| Aug 02, 2024 | POS AM | Filing |
| Jul 31, 2024 | 8-K | Current Report |
| Jul 31, 2024 | 10-Q | Quarterly Report |
| Jun 27, 2024 | 8-K | Current Report |
| Jun 06, 2024 | 8-K | Current Report |